coronaviru
diseas
zoonot
viru
caus
varieti
sever
respiratori
diseas
closest
sarscov
merscov
structur
high
preval
result
lack
symptom
onset
studi
aim
present
overview
viru
term
structur
epidemiolog
symptom
treatment
prevent
whole
genom
sequenc
viral
protein
investig
determin
gap
chang
altern
nucleotid
amino
acid
sequenc
evalu
complet
genom
sequenc
differ
coronavirus
use
bast
mafft
softwar
also
select
seven
type
structur
protein
conclud
might
produc
new
mutat
specif
glycoprotein
caution
complet
prepar
health
author
requir
novel
coronaviru
diseas
first
emerg
decemb
wuhan
citi
china
classifi
seventh
member
subfamili
orthocoronavirina
famili
coronavirida
member
famili
zoonot
virus
transmit
human
contact
infect
anim
although
bat
snake
natur
reservoir
coronavirus
evid
far
origin
transmit
seafood
market
comparison
lipid
raft
coronavirus
indic
new
strain
ident
sever
acut
respiratori
syndrom
coronaviru
sarscov
lipid
molecul
caveolin
clathrin
dynamin
fundament
role
intern
virus
molecul
involv
entri
virus
host
cell
target
host
lipid
studi
antivir
strategi
could
variou
applic
seem
need
bind
angiotensinconvert
receptor
membran
host
cell
enabl
infect
host
cell
upon
coupl
relianc
serin
proteas
intracellular
protein
seem
determin
viru
abil
infect
cell
past
two
decad
outbreak
coronaviru
observedsarscov
middleeast
respiratori
syndrom
mer
covand
describ
major
public
health
threat
consid
seriou
widespread
epidem
diseas
date
seem
mortal
rate
lower
sar
mer
signific
increas
number
case
observ
result
absenc
emerg
patholog
symptom
viru
carrier
reason
may
lead
collaps
local
healthcar
system
countri
face
outbreak
crisi
tri
prevent
spread
prevent
human
gather
impos
curfew
citi
prevent
travel
countri
close
land
border
may
reduc
outbreak
main
transmiss
start
humantohuman
contact
includ
rel
friend
intim
contact
patient
incub
carrier
mani
studi
report
cough
sneez
quicker
rout
viru
dispers
indic
need
droplet
airborn
precaut
encount
infect
person
relat
betacoronaviru
infect
human
probabl
develop
bat
coronavirus
structur
analysi
show
probabl
deriv
bat
sarslik
coronaviru
mutat
spike
glycoprotein
protein
nucleocapsid
n
protein
positivesens
rna
genom
differ
sarscov
merscov
approxim
kb
kb
kb
respect
complet
genom
annot
possess
open
read
frame
orf
encod
protein
sequenc
analysi
reveal
ident
sarscov
merscov
origin
bat
addit
spheric
extern
spike
protein
display
characterist
crown
shape
electron
microscopi
current
studi
new
microb
new
infect
volum
number
c
compar
novel
complet
genom
relat
coronavirus
identifi
mutat
gap
select
data
ncbi
perform
fasta
blast
comparison
genom
align
use
softwar
genbank
sarscov
show
align
ident
respect
fig
show
differ
four
complet
genom
accord
align
analysi
closest
similar
two
genom
compar
two
bat
cov
seven
complet
genom
align
differ
coronaviru
strain
fig
result
reveal
strain
similar
compar
strain
relat
famili
believ
therefor
came
sever
mutat
occur
coronavirus
relat
infect
genom
analysi
support
belief
laboratori
construct
imposs
disprov
prove
theori
origin
identifi
origin
viru
sequenc
obtain
immedi
anim
sourc
first
orf
translat
two
polyprotein
encod
nonstructur
protein
nsp
take
twothird
viral
rna
remain
orf
encod
structur
protein
includ
spike
glycoprotein
small
envelop
e
protein
matrix
protein
nucleocapsid
n
protein
also
possess
accessori
protein
interfer
host
innat
immun
respons
perform
align
genbank
result
show
similar
without
mutat
amino
acid
fig
nucleocapsid
phosphoprotein
genbank
align
np
show
similar
np
sar
cov
bat
cov
similar
respect
fig
crystal
structur
np
releas
march
rcsb
pdb
fig
protein
genbank
align
bat
cov
show
similar
align
hypothet
protein
sar
cov
show
similar
align
put
uncharacter
protein
sar
cov
show
similar
fig
align
protein
genbank
protein
hypothet
protein
bat
sar
cov
hypothet
protein
bat
sar
cov
show
similar
respect
fig
protein
genbank
align
protein
protein
rhinolophu
affini
cov
nsp
sar
cov
show
similar
respect
fig
align
envelop
protein
genbank
ep
show
similar
chain
envelop
small
membran
protein
sar
cov
show
similar
envelop
protein
hypsugo
bat
cov
show
similar
fig
analys
seri
compat
protein
sequenc
studi
confirm
match
strain
obviou
differ
compar
speci
coronaviru
famili
may
indic
origin
mutat
within
coronaviru
famili
clearer
term
new
mutat
may
creat
high
probabl
specif
glycoprotein
unabl
give
reason
explan
signific
number
amino
acid
substitut
sarscov
merscov
due
limit
knowledg
novel
viru
incub
period
viru
may
vari
age
immun
statu
gener
assum
incub
period
day
although
case
observ
day
exposur
main
symptom
easili
seen
age
year
immunocompromis
diabet
individu
symptom
start
fever
dri
cough
dyspnoea
well
sore
throat
nasal
congest
malais
bilater
infiltr
may
seen
chest
xray
howev
case
detect
absenc
fever
clinic
featur
includ
target
lower
airway
well
upper
respiratori
tract
symptom
like
rhinorrhoea
sneez
sore
throat
develop
gastrointestin
symptom
like
diarrhoea
sever
case
may
present
sepsi
heart
attack
even
shock
convers
case
may
show
mild
ill
asymptomat
record
period
symptom
onset
death
rang
day
median
day
period
depend
age
immun
statu
individu
shorter
year
old
prevent
spread
viru
manag
care
patient
requir
earli
identif
rapid
isol
time
establish
infect
prevent
control
measur
togeth
symptomat
care
patient
mild
diseas
support
treatment
need
sever
specif
attent
given
effort
made
reduc
transmiss
suscept
popul
includ
healthcar
provid
immunocompromis
patient
children
elderli
healthcar
system
around
world
must
oper
one
maximum
capac
cooper
healthcar
system
requir
reduc
infect
intern
media
social
media
societ
cultur
use
maintain
person
clean
minim
risk
exposur
avoid
gather
prevent
phenomena
lead
contact
person
vaccin
acceler
develop
global
public
health
commun
must
consid
effect
mass
gather
cancel
futur
wellb
commun
econom
recess
well
spread
otherwis
quantit
rtpcr
specif
sensit
assay
approv
straightforwardli
use
mani
refer
laboratori
worldwid
laboratori
test
may
help
assess
diseas
sever
predict
risk
evolut
acut
respiratori
distress
syndrom
dissemin
intravascular
coagul
multiorgan
failur
moreov
creactiv
protein
lactat
dehydrogenas
erythrocyt
sediment
rate
ddimer
along
diminish
concentr
serum
albumin
increas
valu
lactat
dehydrogenas
aspart
aminotransferas
alanin
aminotransferas
total
bilirubin
creatinin
cardiac
troponin
use
help
test
organ
function
notabl
combin
igmigg
rapid
immunoassay
also
recent
develop
well
investig
elev
proinflammatori
cytokin
detect
kit
basic
granulocyt
colonystimul
factor
tumour
necrosi
induc
protein
studi
reveal
gastrointestin
symptom
associ
viral
rna
faecal
sampl
extend
durat
viral
rna
posit
faec
rna
isol
human
saliva
nasopharynx
lower
respiratori
tract
comput
tomographi
find
lung
abnorm
increas
quickli
onset
symptom
persist
long
durat
comput
tomographi
manifest
import
inspect
pattern
time
studi
show
evid
tumour
necrosi
inhibit
increas
risk
outbreak
current
approv
antivir
treatment
implement
antivir
treatment
prophylaxi
sever
requir
reduc
risk
drug
administ
shortli
symptom
onset
reduc
infecti
shed
viru
respiratori
secret
studi
indic
hydroxychloroquin
antivir
activ
vitro
coronavirus
specif
remark
drug
licens
chemoprophylaxi
treatment
malaria
furthermor
drug
test
suggest
prophylaxi
hydroxychloroquin
approv
dose
may
prevent
infect
amend
viral
shed
clinic
trial
hydroxychloroquin
treatment
pneumonia
shown
posit
preliminari
outcom
china
unfortun
corticosteroid
treatment
commonli
use
clinic
practic
influenza
viru
acyclovir
ganciclovir
ribavirin
methylprednisolon
well
neuraminidas
inhibitor
includ
peramivir
oseltamivir
zanamivir
invalid
recommend
scientist
made
progress
character
new
coronaviru
still
mani
question
answer
great
biolog
hazard
worldwid
threat
highli
contagi
latenc
period
may
necessari
adopt
invest
modern
technolog
facilit
notif
allow
speedier
data
dissemin
analysi
keep
principl
precis
epidemiolog
suggest
close
contact
infect
person
major
factor
diseas
transmiss
healthcar
worker
must
also
follow
cdc
guidelin
attempt
perform
viru
isol
character
effect
mass
gather
cancel
reduc
spread
need
determin
mutat
occur
especi
import
evid
part
synthet
author
declar
conflict
interest
